![]() |
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
BRIEF-Merck, Pfizer say investigational Ertugliflozin met primary endpoint
* Merck and Pfizer an**unce investigational Ertugliflozinmet primary endpoint of A1C reduction when added to Sitagliptinand Metformin in people with type 2 diabetes ??????? ??????: BRIEF-Merck, Pfizer say investigational Ertugliflozin met primary endpoint || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|